SIBO: Complete Guide for Brazilian Expats and International Patients

If you have been battling persistent bloating, gas, abdominal pain, brain fog, or unpredictable bowel habits — and no one has been able to explain why — Small Intestinal Bacterial Overgrowth (SIBO) may be the missing piece. As a Brazilian nutritionist who works with patients across multiple countries, I have seen SIBO hide behind “IBS”, “stress”, and “just a sensitive stomach” for years before being identified. This comprehensive guide explains what SIBO is, how it is diagnosed, the hydrogen/methane/hydrogen-sulfide subtypes, and what a specialized nutrition protocol actually looks like.

By Taissa Castello, registered nutritionist CRN-4 25106120, specialized in gut health, SIBO, celiac disease, and food allergies. English teleconsultations available worldwide.

What is SIBO?

Small Intestinal Bacterial Overgrowth (SIBO) is a condition in which an excessive number of bacteria — often of colonic origin — colonize the small intestine. Normally, the small intestine hosts far fewer bacteria than the colon, because this is where most nutrient absorption takes place. When bacteria overgrow in the wrong compartment, they ferment carbohydrates before your body can absorb them, producing excess gases (hydrogen, methane, and sometimes hydrogen sulfide) and causing the classic symptoms of bloating, distension, altered bowel habits, and abdominal pain (Pimentel et al., 2020).

SIBO is not a “fashionable” diagnosis. It is recognized by the American College of Gastroenterology (ACG) 2020 Clinical Guideline and the North American Consensus as a distinct clinical entity with validated breath-test criteria (Rezaie et al., 2017; Pimentel et al., 2020). Prevalence estimates vary widely depending on the population studied, but SIBO is disproportionately common in patients with IBS, post-infectious gastroenteritis, hypothyroidism, diabetes, scleroderma, previous abdominal surgery, and chronic proton pump inhibitor use.

“SIBO is often the root cause behind years of unexplained digestive symptoms. Once we address the bacterial overgrowth and restore the gut’s natural defenses, patients often experience relief they did not think was possible.”

— Taissa Castello, PodIgest

Symptoms — digestive and beyond

SIBO rarely presents as a single symptom. Most patients describe a cluster of complaints that fluctuate over time and often worsen after meals rich in fermentable carbohydrates. The most consistent findings in the literature are:

• Bloating and abdominal distension — often dramatically worse in the afternoon and evening
• Excess gas — belching, flatulence, gurgling sounds
• Altered bowel habits — diarrhea, constipation, or alternating patterns
• Abdominal pain or cramping
• Post-meal fatigue or brain fog
• Nutrient deficiencies — particularly iron, vitamin B12, and fat-soluble vitamins (A, D, E, K)
• Unintentional weight changes — weight loss in classic presentations, weight retention in methane-dominant SIBO
• Skin issues — rosacea is strongly associated with SIBO in the literature

If this list sounds like your daily reality, you are not “complaining too much” and you are not alone. A proper evaluation is the first step.

The three SIBO subtypes: hydrogen, methane, and hydrogen sulfide

SIBO is not a single disease. The gases produced by the overgrown microbes shape the clinical picture, influence which antimicrobial protocol works, and predict relapse patterns.

Hydrogen-dominant SIBO

Hydrogen is produced by bacterial fermentation of carbohydrates in the small intestine. Hydrogen-dominant SIBO typically presents with diarrhea-predominant symptoms, frequent urgency, and postprandial bloating. It generally responds well to rifaximin-based protocols combined with a targeted low-fermentation diet (Pimentel et al., 2020).

Intestinal Methanogen Overgrowth (IMO)

Formerly called “methane-dominant SIBO”, the North American Consensus now uses the term Intestinal Methanogen Overgrowth (IMO) because the responsible organism — Methanobrevibacter smithii — is an archaeon, not a bacterium, and it can overgrow in both the small and large intestine (Pimentel et al., 2020). IMO is the methane-producing form and is strongly associated with constipation, slower gut motility, and difficulty losing weight. Treatment typically requires a dual antimicrobial approach (rifaximin plus neomycin or rifaximin plus allicin) because methane archaea are less sensitive to rifaximin alone.

Hydrogen sulfide SIBO (H2S)

The newest recognized subtype. Hydrogen sulfide is produced by sulfate-reducing bacteria and is associated with “rotten egg” gas, diarrhea, and visceral hypersensitivity. Detection requires a three-gas breath test (trio-smart or equivalent). Management involves restriction of high-sulfur foods during the acute phase alongside targeted antimicrobials.

For a deeper comparison of hydrogen and methane SIBO — why the breath test matters, how treatment differs, and what weight and bowel patterns tell you — see the detailed article (in Portuguese): SIBO de hidrogênio vs. metano (IMO).

How is SIBO diagnosed?

The gold-standard diagnostic test in clinical practice is the breath test. After an overnight fast and a 24-hour low-fermentation preparation diet, the patient drinks a substrate (usually lactulose or glucose) and breath samples are collected every 15-20 minutes for 2-3 hours. Elevated hydrogen, methane, or hydrogen sulfide above validated thresholds confirms overgrowth (Rezaie et al., 2017).

• Lactulose breath test: travels the full length of the small intestine — better at detecting distal SIBO, slightly higher false positives
• Glucose breath test: absorbed in the proximal small intestine — higher specificity, lower sensitivity for distal overgrowth
• Trio-smart (three-gas): measures H2, CH4, and H2S — required to detect hydrogen sulfide SIBO

A small-bowel aspirate and culture remain the theoretical gold standard but are invasive and rarely used outside research settings. In my practice, a well-prepared breath test plus a thorough clinical history is what we use to guide treatment decisions.

Root causes: why SIBO happens

SIBO is almost never the primary disease — it is a consequence of something else disrupting the gut’s natural defenses. Identifying and addressing the underlying cause is what separates a one-time recovery from a lifetime of relapses.

• Impaired migrating motor complex (MMC) — the “housekeeper wave” that sweeps bacteria out of the small intestine between meals. Often damaged after food poisoning (post-infectious IBS)
• Low stomach acid — from chronic PPI use, H. pylori, or age-related hypochlorhydria
• Anatomical changes — adhesions from previous abdominal surgery, diverticula, strictures
• Hypothyroidism — slows gut motility; strongly associated with methane-dominant SIBO
• Diabetes and scleroderma — autonomic neuropathy affecting gut motility
• Chronic constipation — itself both cause and consequence
• Ileocecal valve dysfunction — allowing colonic bacteria to reflux into the small intestine

“When a patient relapses again and again, the question is never ‘why did the SIBO come back?’ — it is ‘what in your system is still allowing the bacteria to overgrow?’ That is where the real work happens.”

— Taissa Castello, PodIgest

Treatment: antimicrobial, nutrition, and motility

Effective SIBO treatment is a three-legged stool: kill the overgrowth, feed yourself without feeding the overgrowth, and restore motility so it does not come back. Skipping any leg predicts relapse.

1. Antimicrobial phase

Pharmaceutical options (prescribed by a gastroenterologist) include rifaximin for hydrogen-dominant SIBO and rifaximin + neomycin for methane-dominant IMO (Pimentel et al., 2020). Herbal antimicrobials — oregano oil, berberine, neem, and allicin — have shown comparable efficacy in a randomized trial and are useful when pharmaceuticals are unavailable or not tolerated (Chedid et al., 2014).

2. Nutritional phase

Dietary strategies reduce the fermentable substrate available to bacteria, easing symptoms during and shortly after antimicrobial treatment. The most commonly used in clinical practice are the low-FODMAP diet, the SIBO Specific Food Guide (SSFG), and the SIBO Bi-Phasic Diet. None should be permanent — prolonged restriction starves beneficial bacteria and can worsen long-term gut health (Staudacher et al., 2017).

3. Motility and prevention

This is the phase most protocols skip — and it is why people relapse. Prokinetic agents (prescription or natural), adequate spacing between meals (4-5 hours to allow the MMC to fire), stress reduction, and treating underlying causes (thyroid, stomach acid, adhesions) are what keep SIBO from returning. For a detailed walkthrough of post-treatment recovery, see (in Portuguese): SIBO pós-tratamento.

SIBO and IBS — the same thing?

No — but they overlap significantly. Studies using breath testing suggest that up to 60-80% of patients with IBS meet criteria for SIBO (Ghoshal et al., 2017). That does not mean every IBS patient has SIBO, but it does mean that a diagnosis of “IBS” without further investigation leaves a large share of patients without an actionable treatment plan. If you have been told you have IBS and standard management is not working, asking about a breath test is reasonable.

SIBO and thyroid disease

Hypothyroidism — particularly Hashimoto’s thyroiditis — is strongly associated with methane-dominant SIBO. The slowed gut motility from low thyroid hormone creates the perfect environment for archaea to overgrow, and many patients present with constipation that is resistant to standard laxative approaches. Treating SIBO in these patients often improves thyroid medication absorption and symptom burden simultaneously. See the companion article on Hashimoto’s thyroiditis and gluten.

Frequently asked questions

Can SIBO be cured or only managed?

SIBO can be fully cleared, but the underlying cause determines long-term outcomes. Patients with a transient trigger (a single food poisoning episode, a short PPI course) often achieve durable remission. Patients with structural causes (adhesions, scleroderma) or chronic motility disease may need ongoing prokinetic support.

Is the low-FODMAP diet a cure for SIBO?

No. The low-FODMAP diet reduces symptoms but does not eliminate the overgrowth. It is a symptom-management tool used during and shortly after antimicrobial treatment — not a permanent diet.

How long does SIBO treatment take?

A typical protocol runs 2-4 weeks of antimicrobials followed by a 4-8 week nutrition and motility phase. Patients with high breath gas values or structural causes may need repeated courses. Expect 3-6 months for full recovery with a well-designed protocol.

Can I treat SIBO while traveling or living abroad?

Yes. Breath tests are available in most major cities worldwide, and teleconsultations allow nutritional and protocol guidance regardless of your location. In my practice I work with patients across Brazil, Europe, North America, and the Middle East using video consultations.

Key takeaways

• SIBO is a real, measurable condition — not a label for unexplained bloating
• Three subtypes (hydrogen, methane/IMO, hydrogen sulfide) require different strategies
• Diagnosis via validated breath testing (Rezaie et al., 2017)
• Treatment is a three-legged stool: antimicrobial + nutrition + motility
• Underlying root causes must be addressed to prevent relapse
• Specialized nutritional support significantly improves outcomes

Ready to take the next step?

If you are looking for specialized nutritional guidance, Taissa Castello offers teleconsultations via Google Meet for patients worldwide. Whether you live in Brazil or abroad, you can get expert, personalized support for your gut health, autoimmune condition, or food allergies — in English or Portuguese.

Or visit the booking page for more options.

References

• Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. Am J Gastroenterol. 2020;115(2):165-178.
• Rezaie A, Buresi M, Lembo A, et al. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. Am J Gastroenterol. 2017;112(5):775-784.
• Chedid V, Dhalla S, Clarke JO, et al. Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth. Glob Adv Health Med. 2014;3(3):16-24.
• Ghoshal UC, Shukla R, Ghoshal U. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy. Gut Liver. 2017;11(2):196-208.
• Staudacher HM, Whelan K. The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS. Gut. 2017;66(8):1517-1527.
• Lauritano EC, Gabrielli M, Scarpellini E, et al. Small intestinal bacterial overgrowth recurrence after antibiotic therapy. Am J Gastroenterol. 2008;103(8):2031-2035.

Medical Disclaimer: This article is for informational and educational purposes only. It does not replace individualized medical or nutritional advice, diagnosis, or treatment. Each person has unique needs that must be evaluated in a consultation. Do not start, change, or stop any treatment without guidance from a qualified healthcare professional. Taissa Castello is a registered nutritionist (CRN-4 25106120) and does not prescribe medications. Read our full disclaimer.